vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and CARRIAGE SERVICES INC (CSV). Click either name above to swap in a different company.

CARRIAGE SERVICES INC is the larger business by last-quarter revenue ($105.5M vs $77.6M, roughly 1.4× Bioceres Crop Solutions Corp.). CARRIAGE SERVICES INC runs the higher net margin — 11.6% vs -9.6%, a 21.2% gap on every dollar of revenue. On growth, CARRIAGE SERVICES INC posted the faster year-over-year revenue change (8.0% vs -16.8%). Over the past eight quarters, CARRIAGE SERVICES INC's revenue compounded faster (1.0% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.

BIOX vs CSV — Head-to-Head

Bigger by revenue
CSV
CSV
1.4× larger
CSV
$105.5M
$77.6M
BIOX
Growing faster (revenue YoY)
CSV
CSV
+24.8% gap
CSV
8.0%
-16.8%
BIOX
Higher net margin
CSV
CSV
21.2% more per $
CSV
11.6%
-9.6%
BIOX
Faster 2-yr revenue CAGR
CSV
CSV
Annualised
CSV
1.0%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
CSV
CSV
Revenue
$77.6M
$105.5M
Net Profit
$-7.4M
$12.3M
Gross Margin
46.8%
34.8%
Operating Margin
9.3%
23.3%
Net Margin
-9.6%
11.6%
Revenue YoY
-16.8%
8.0%
Net Profit YoY
-20.2%
24.5%
EPS (diluted)
$-0.12
$0.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
CSV
CSV
Q4 25
$105.5M
Q3 25
$77.6M
$102.7M
Q2 25
$102.1M
Q1 25
$60.6M
$107.1M
Q4 24
$98.8M
$97.7M
Q3 24
$93.3M
$100.7M
Q2 24
$102.3M
Q1 24
$84.0M
$103.5M
Net Profit
BIOX
BIOX
CSV
CSV
Q4 25
$12.3M
Q3 25
$-7.4M
$6.6M
Q2 25
$11.7M
Q1 25
$-1.6M
$20.9M
Q4 24
$605.2K
$9.9M
Q3 24
$-6.2M
$9.9M
Q2 24
$6.3M
Q1 24
$9.8M
$7.0M
Gross Margin
BIOX
BIOX
CSV
CSV
Q4 25
34.8%
Q3 25
46.8%
35.3%
Q2 25
35.2%
Q1 25
39.4%
35.3%
Q4 24
42.0%
34.4%
Q3 24
40.2%
35.2%
Q2 24
36.2%
Q1 24
50.8%
36.0%
Operating Margin
BIOX
BIOX
CSV
CSV
Q4 25
23.3%
Q3 25
9.3%
17.0%
Q2 25
23.5%
Q1 25
1.5%
29.5%
Q4 24
14.5%
21.6%
Q3 24
2.5%
22.7%
Q2 24
18.0%
Q1 24
15.7%
18.8%
Net Margin
BIOX
BIOX
CSV
CSV
Q4 25
11.6%
Q3 25
-9.6%
6.4%
Q2 25
11.5%
Q1 25
-2.6%
19.5%
Q4 24
0.6%
10.1%
Q3 24
-6.6%
9.8%
Q2 24
6.1%
Q1 24
11.6%
6.7%
EPS (diluted)
BIOX
BIOX
CSV
CSV
Q4 25
$0.76
Q3 25
$-0.12
$0.41
Q2 25
$0.74
Q1 25
$-0.02
$1.34
Q4 24
$0.00
$0.62
Q3 24
$-0.10
$0.63
Q2 24
$0.40
Q1 24
$0.14
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
CSV
CSV
Cash + ST InvestmentsLiquidity on hand
$15.5M
$1.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$288.3M
$254.8M
Total Assets
$734.9M
$1.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
CSV
CSV
Q4 25
$1.7M
Q3 25
$15.5M
$1.2M
Q2 25
$1.4M
Q1 25
$38.5M
$4.6M
Q4 24
$29.2M
$1.2M
Q3 24
$32.3M
$1.3M
Q2 24
$1.5M
Q1 24
$16.4M
$1.7M
Stockholders' Equity
BIOX
BIOX
CSV
CSV
Q4 25
$254.8M
Q3 25
$288.3M
$242.1M
Q2 25
$235.4M
Q1 25
$345.0M
$223.1M
Q4 24
$346.3M
$208.6M
Q3 24
$346.0M
$198.1M
Q2 24
$187.9M
Q1 24
$348.5M
$179.6M
Total Assets
BIOX
BIOX
CSV
CSV
Q4 25
$1.3B
Q3 25
$734.9M
$1.3B
Q2 25
$1.3B
Q1 25
$798.2M
$1.3B
Q4 24
$835.2M
$1.3B
Q3 24
$827.3M
$1.3B
Q2 24
$1.3B
Q1 24
$836.1M
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
CSV
CSV
Operating Cash FlowLast quarter
$14.4M
$14.1M
Free Cash FlowOCF − Capex
$6.2M
FCF MarginFCF / Revenue
5.9%
Capex IntensityCapex / Revenue
7.5%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$40.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
CSV
CSV
Q4 25
$14.1M
Q3 25
$14.4M
$24.7M
Q2 25
$8.1M
Q1 25
$23.3M
$13.8M
Q4 24
$-5.4M
$9.3M
Q3 24
$5.2M
$20.9M
Q2 24
$2.2M
Q1 24
$-17.4M
$19.7M
Free Cash Flow
BIOX
BIOX
CSV
CSV
Q4 25
$6.2M
Q3 25
$18.0M
Q2 25
$5.2M
Q1 25
$10.6M
Q4 24
$4.9M
Q3 24
$16.2M
Q2 24
$-1.4M
Q1 24
$16.2M
FCF Margin
BIOX
BIOX
CSV
CSV
Q4 25
5.9%
Q3 25
17.5%
Q2 25
5.1%
Q1 25
9.9%
Q4 24
5.0%
Q3 24
16.1%
Q2 24
-1.4%
Q1 24
15.6%
Capex Intensity
BIOX
BIOX
CSV
CSV
Q4 25
7.5%
Q3 25
6.5%
Q2 25
2.8%
Q1 25
3.0%
Q4 24
4.5%
Q3 24
4.6%
Q2 24
3.5%
Q1 24
3.4%
Cash Conversion
BIOX
BIOX
CSV
CSV
Q4 25
1.15×
Q3 25
3.76×
Q2 25
0.69×
Q1 25
0.66×
Q4 24
-8.85×
0.94×
Q3 24
2.11×
Q2 24
0.34×
Q1 24
-1.78×
2.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

CSV
CSV

Propertyand Merchandise$47.8M45%
Cemetery Interment Rights$24.8M23%
Merchandise$18.9M18%
Other Revenue$10.2M10%
Other$3.9M4%

Related Comparisons